Here are five observations:
1. The market is estimated to reach $16.7 billion by 2025, up from $10.2 billion in 2016.
2. The fusion segment is expected to maintain its dominance with the largest market share.
3. North America continues to lead the global market.
4. Insurance coverage expansion and chronic disease growth will boost Europe’s spine surgery products market.
5. Drawn-out product approvals and clinical trial failures could hinder market growth.
More articles on devices:
Diamond Orthopedic aims to penetrate ASC market with FDA clearance for orthopedic screws
CoreLink acquires medical device company: 5 key details
Stryker sells product line to 3T: 4 highlights
